Communications Medicine

Fig. 2: Survival data. | Communications Medicine

Fig. 2: Survival data.

From: Progression-free survival for unresectable non-metastatic locally advanced pancreatic cancer after surgical microwave ablation plus durvalumab and tremelimumab: phase-2 non-randomized prospective clinical trial

Fig. 2

Search

Advanced search

Quick links